Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Mental Health in Multiple Sclerosis Patients without Limitation of Physical Function: The Role of Physical Activity.
Soluble Tumor Necrosis Factor Receptor 1 Released by Skin-Derived Mesenchymal Stem Cells Is Critical for Inhibiting Th17 Cell Differentiation.
Recommendations for observational studies of comorbidity in multiple sclerosis.
Therapeutic strategies targeting B-cells in multiple sclerosis.
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
Neuroinflammation: The Devil is in the Details.
Early detection of thrombin activity in neuroinflammatory disease.
Different Mechanisms Regulate Expression of Zebrafish Myelin P0 in Myelinating Oligodendrocytes and its Induction Following Axonal Injury.
Current Perspectives on Interferon Beta-1b for the Treatment of Multiple Sclerosis.
What is the Real Fate of Vitamin D in Multiple Sclerosis?
A novel PEGylated interferon beta-1a for multiple sclerosis: safety, pharmacology, and biology.
Evasion of Antiviral Innate Immunity by Theiler's Virus L* Protein through Direct Inhibition of RNase L.
Immunity and inflammation in neurodegenerative diseases.
Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.
Russell W Brain and the aetiology of multiple sclerosis--a historical perspective.
The use of transcranial magnetic stimulation in diagnosis, prognostication and treatment evaluation in multiple sclerosis.
Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis.
[Assessment of the size of the thalamus as a method for the evaluation of the activity of neurodegenerative process after the treatment with cerebrolisin in young patients with multiple sclerosis.]
The Outlook for Alemtuzumab in Multiple Sclerosis.
Ipilimumab in patients with melanoma and autoimmune disease.
Inflammation negatively regulates FOXP3 and regulatory T-cell function via DBC1.
Walking Speed and Brain Glucose Uptake are Uncoupled in Patients with Multiple Sclerosis.
Variables Related to Working Capability among Swiss Patients with Multiple Sclerosis-A Cohort Study.
In vitro myelin formation using embryonic stem cells.
Restoring nervous system structure and function using tissue engineered living scaffolds.
Pages
« first
‹ previous
…
578
579
580
581
582
583
584
585
586
…
next ›
last »